Stock News

Medicines Co (MDCO) Holder Slate Path Capital LP Has Raised Its Stake by $16.74 Million; As Halliburton Co (HAL) Stock Value Declined, Edge Wealth Management Has Boosted Stake

The Medicines Company (NASDAQ:MDCO) Logo

Edge Wealth Management Llc increased its stake in Halliburton Co (HAL) by 3006.06% based on its latest 2017Q4 regulatory filing with the SEC. Edge Wealth Management Llc bought 43,137 shares as the company’s stock declined 2.35% with the market. The institutional investor held 44,572 shares of the oilfield services and equipment company at the end of 2017Q4, valued at $2.18 million, up from 1,435 at the end of the previous reported quarter. Edge Wealth Management Llc who had been investing in Halliburton Co for a number of months, seems to be bullish on the $44.63 billion market cap company. The stock increased 0.47% or $0.24 during the last trading session, reaching $51. About 3.89M shares traded. Halliburton Company (NYSE:HAL) has declined 1.88% since April 17, 2017 and is downtrending. It has underperformed by 13.43% the S&P500.

David Greenspan increased its stake in Medicines Co (MDCO) by 55.86% based on its latest 2017Q4 regulatory filing with the SEC. Slate Path Capital Lp bought 620,000 shares as the company’s stock rose 23.35% while stock markets declined. The hedge fund run by David Greenspan held 1.73 million shares of the major pharmaceuticals company at the end of 2017Q4, valued at $47.30 million, up from 1.11 million at the end of the previous reported quarter. Slate Path Capital Lp who had been investing in Medicines Co for a number of months, seems to be bullish on the $2.23 billion market cap company. The stock increased 2.42% or $0.72 during the last trading session, reaching $30.44. About 375,312 shares traded. The Medicines Company (NASDAQ:MDCO) has declined 34.73% since April 17, 2017 and is downtrending. It has underperformed by 46.28% the S&P500.

Among 11 analysts covering The Medicines Co (NASDAQ:MDCO), 11 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. The Medicines Co had 37 analyst reports since August 28, 2015 according to SRatingsIntel. As per Wednesday, August 30, the company rating was maintained by Chardan Capital Markets. The firm earned “Buy” rating on Monday, June 26 by Jefferies. The firm has “Neutral” rating by Citigroup given on Monday, July 17. The company was initiated on Monday, October 23 by Guggenheim. The rating was maintained by RBC Capital Markets with “Outperform” on Wednesday, November 16. The stock has “Hold” rating by Oppenheimer on Thursday, August 10. Leerink Swann maintained The Medicines Company (NASDAQ:MDCO) on Monday, August 31 with “Buy” rating. On Monday, November 16 the stock rating was maintained by RBC Capital Markets with “Outperform”. On Wednesday, July 26 the stock rating was maintained by Citigroup with “Neutral”. Oppenheimer maintained the shares of MDCO in report on Thursday, February 22 with “Hold” rating.

Investors sentiment increased to 1.25 in 2017 Q4. Its up 0.47, from 0.78 in 2017Q3. It increased, as 26 investors sold MDCO shares while 51 reduced holdings. 28 funds opened positions while 68 raised stakes. 89.44 million shares or 5.03% more from 85.15 million shares in 2017Q3 were reported. California-based Partner Invest LP has invested 1.06% in The Medicines Company (NASDAQ:MDCO). Moreover, Riverhead Mngmt has 0.01% invested in The Medicines Company (NASDAQ:MDCO). Global X Mgmt Ltd Liability holds 651 shares or 0% of its portfolio. Corvex Mngmt Limited Partnership holds 2.41 million shares or 3.16% of its portfolio. 91,110 were accumulated by Sei Investments. Assetmark Incorporated holds 21 shares. Arizona State Retirement Systems holds 0.03% or 107,819 shares in its portfolio. Amalgamated Bancorp holds 10,022 shares. Principal holds 0.01% or 499,984 shares. Barclays Plc has invested 0% in The Medicines Company (NASDAQ:MDCO). Old West Investment Mngmt Lc reported 0.12% stake. Profund Ltd Liability Corp holds 0.01% of its portfolio in The Medicines Company (NASDAQ:MDCO) for 12,214 shares. Antipodean Lc holds 2.18% or 98,000 shares. Northern owns 887,878 shares. Ameritas Ptnrs Inc invested in 0.01% or 6,058 shares.

Since December 7, 2017, it had 1 buying transaction, and 2 insider sales for $1.36 million activity. 7,500 shares were sold by CROUSE WILLIAM, worth $241,950. ESHELMAN FREDRIC N bought 200,000 shares worth $5.31 million.

Slate Path Capital Lp, which manages about $4.31B and $1.02 billion US Long portfolio, decreased its stake in Dxc Technology Co by 325,000 shares to 810,000 shares, valued at $76.87M in 2017Q4, according to the filing. It also reduced its holding in Charter Communications Inc N by 305,000 shares in the quarter, leaving it with 300,000 shares, and cut its stake in Alnylam Pharmaceuticals Inc (NASDAQ:ALNY).

Since January 2, 2018, it had 0 insider purchases, and 10 sales for $8.39 million activity. Another trade for 39,287 shares valued at $2.16 million was sold by Voyles Robb L.. 12,977 shares were sold by Brown James S, worth $713,475 on Monday, January 22. Miller Jeffrey Allen sold 29,025 shares worth $1.60M. $151,459 worth of Halliburton Company (NYSE:HAL) shares were sold by Beaty Anne L.. McKeon Timothy also sold $251,835 worth of Halliburton Company (NYSE:HAL) on Monday, January 22.

Among 42 analysts covering Halliburton Company (NYSE:HAL), 37 have Buy rating, 0 Sell and 5 Hold. Therefore 88% are positive. Halliburton Company had 152 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Halliburton Company (NYSE:HAL) earned “Buy” rating by RBC Capital Markets on Thursday, December 21. The firm has “Buy” rating given on Monday, May 16 by Citigroup. The stock of Halliburton Company (NYSE:HAL) has “Hold” rating given on Tuesday, October 24 by Cowen & Co. The firm has “Buy” rating given on Tuesday, January 23 by Bernstein. The stock of Halliburton Company (NYSE:HAL) earned “Hold” rating by HSBC on Tuesday, January 26. Piper Jaffray maintained Halliburton Company (NYSE:HAL) on Monday, July 24 with “Buy” rating. The firm earned “Buy” rating on Monday, May 29 by Jefferies. The firm earned “Accumulate” rating on Tuesday, July 21 by Global Hunter Securities. The firm earned “Buy” rating on Wednesday, January 13 by Seaport Global. The rating was maintained by RBC Capital Markets with “Buy” on Thursday, July 20.

Investors sentiment increased to 1.15 in Q4 2017. Its up 0.30, from 0.85 in 2017Q3. It improved, as 54 investors sold HAL shares while 283 reduced holdings. 125 funds opened positions while 261 raised stakes. 675.47 million shares or 0.60% less from 679.57 million shares in 2017Q3 were reported. Epoch Inv holds 0.12% or 738,402 shares. Virginia Retirement Sys Et Al stated it has 14,624 shares. 90,075 are owned by First Republic Mgmt. Swiss National Bank accumulated 3.21 million shares. Salem Capital Management owns 1.75% invested in Halliburton Company (NYSE:HAL) for 70,550 shares. Principal Financial Gp Inc, a Iowa-based fund reported 1.63 million shares. Washington National Bank & Trust reported 74,352 shares stake. Ashfield Cap Ptnrs Ltd Liability Company accumulated 7,651 shares or 0.05% of the stock. 45,540 are held by Train Babcock Advsr Limited Liability Corporation. The California-based Dodge Cox has invested 0% in Halliburton Company (NYSE:HAL). Huntington Comml Bank holds 0.06% of its portfolio in Halliburton Company (NYSE:HAL) for 80,644 shares. Moreover, Caprock Grp Inc has 0.08% invested in Halliburton Company (NYSE:HAL). 111,015 were accumulated by Arrowgrass Partners (Us) Limited Partnership. Highbridge Mngmt Limited Liability invested in 0.01% or 8,300 shares. Acg Wealth owns 0.13% invested in Halliburton Company (NYSE:HAL) for 18,397 shares.

Edge Wealth Management Llc, which manages about $803.39 million and $353.06 million US Long portfolio, decreased its stake in Costco Wholesale Corp (NASDAQ:COST) by 6,072 shares to 40 shares, valued at $7,000 in 2017Q4, according to the filing. It also reduced its holding in Cvs Health Corp (NYSE:CVS) by 79,583 shares in the quarter, leaving it with 26,868 shares, and cut its stake in Barrick Gold Corp (NYSE:ABX).

The Medicines Company (NASDAQ:MDCO) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *